Pathology showed C-SCLC composed of 70% squamous cell carcinoma and 30% small-cell carcinoma (Ki-67: 60%), with vascular invasion, pleural and bone infiltration, and nodal metastases (pT3N1Mx). The gene discussed is MKI67; the disease is small cell lung carcinoma.